In Brief: FDA prioritizes inspections, McClellan on J&J board, Unilever told to pull Flora ProActiv ads, NAD reminds firms to support testimonials
This article was originally published in The Tan Sheet
Executive Summary
FDA on shutdown; McClellan on J&J board; Unilever told to pull U.K. Flora ProActiv ads; ERSP: dose must deliver nutritional benefits; NAD: firms must support testimonials; CPSC considers recall regs; Sabinsa’s Curcumin C3 is GRAS.